VGF in cerebrospinal fluid, when combined with conventional biomarkers, enhances prediction of conversion from mild cognitive impairment to Alzheimer Disease.

Authors

Daniel Llano

Published

January 7, 2019

Add a comment...

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/512939

License

CC-BY

Other Formats

PDF

VGF in cerebrospinal fluid, when combined with conventional biomarkers, enhances prediction of conversion from mild cognitive impairment to Alzheimer Disease.

Authors

Daniel Llano

Published

January 7, 2019

Add a comment...

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/512939

License

CC-BY

Other Formats

PDF

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/512939

License

CC-BY

Other Formats

PDF

Paper

Paper

Paper

Paper

VGF in cerebrospinal fluid, when combined with conventional biomarkers, enhances prediction of conversion from mild cognitive impairment to Alzheimer Disease.

Supporters

Preprint Server

Topics

DOI

License

Other Formats

VGF in cerebrospinal fluid, when combined with conventional biomarkers, enhances prediction of conversion from mild cognitive impairment to Alzheimer Disease.

Supporters

Preprint Server

Topics

DOI

License

Other Formats

Supporters

Preprint Server

Topics

DOI

License

Other Formats